Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
Alarming situation has been caused due to the emergence of COVID-19 infection around the world. There is an urgency of developing a therapeutic strategy in order to control the spread of COVID-19. Towards that initiative, potential drugs like hydroxychloroquine, ivermectin and azithromycin have been...
Main Authors: | R. Choudhary, A.K. Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | New Microbes and New Infections |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2052297520300366 |
Similar Items
-
Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
by: Aditya Kapoor, et al.
Published: (2021-01-01) -
Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
by: Elisa Baranski Lamback, et al.
Published: (2021-03-01) -
Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01) -
Is ivermectin–Azithromycin combination the next step for COVID-19?
by: Hayder Mutter Al-Kuraishy, et al.
Published: (2020-01-01) -
Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
by: Mondher Toumi, et al.
Published: (2020-01-01)